Tue, 02/04/2025 - 05:57 |
PathMaker Neurosystems Announces IRB Approval for DoD-funded Clinical Trial of the MyoRegulator Device in ALS |
PathMaker Neuro... |
Thu, 08/22/2024 - 08:09 |
Sean M. Healey & AMG Center for ALS and Les Turner ALS Center at Northwestern Medicine Establish Acceleration Centers of Enrollment Initiative |
Massachusetts G... |
Tue, 07/16/2024 - 04:16 |
Healey & AMG Center for ALS Announces New Investigational Drug Monepantel from PharmAust Limited will begin design for inclusion in HEALEY ALS Platform Trial |
Massachusetts G... |
Fri, 06/21/2024 - 18:52 |
Scientists identify genes linked to brain cell loss in ALS |
NIH |
Tue, 06/18/2024 - 10:51 |
Blood Markers Detect Rare Forms of Dementia as well as the Neurological Diseases ALS and PSP |
BonnUniv |
Thu, 06/06/2024 - 01:46 |
PathMaker Neurosystems Announces $2.16 Million Award from U.S. Department of Defense for ALS Clinical Trial |
PathMaker Neuro... |
Wed, 06/05/2024 - 02:03 |
The Sean M. Healey & AMG Center for ALS in Partnership with ALS Finding a Cure and Fight MND Announce 2024 ALS Scholars in Therapeutics Recipients |
Massachusetts G... |
Sun, 12/04/2022 - 19:47 |
Healey & AMG Center for ALS announces new drug regimen for testing DNL343 in HEALEY ALS Platform Trial |
Massachusetts G... |
Mon, 10/17/2022 - 08:05 |
FDA Awards 19 Grants and Two Contracts Related to Rare Diseases, including ALS |
FDA |
Thu, 09/29/2022 - 19:11 |
HEALEY ALS Platform Trial |
Massachusetts G... |
Wed, 09/28/2022 - 20:25 |
FDA Approves New Treatment Option for Patients with ALS |
FDA |
Tue, 07/12/2022 - 08:32 |
Investigational drug ABBV-CLS-7262 initiates design phase for entry into the HEALEY ALS Platform Trial |
Massachusetts G... |
Tue, 06/07/2022 - 21:26 |
Director of Sean M. Healey & AMG Center for ALS Named Co-chair of NINDS ALS Optimizing Clinical Research Strategic Planning Effort |
Massachusetts G... |
Wed, 05/18/2022 - 10:52 |
New ALS drug is more effective than existing ones |
Northwestern Un... |
Mon, 05/09/2022 - 18:45 |
EISAI INITIATES PREPARATION FOR NEW DRUG APPLICATION, BASED ON THE RESULTS OF AN INVESTIGATOR-INITIATED CLINICAL TRIAL OF ULTRAHIGH-DOSE MECOBALAMIN FOR AMYOTROPHIC LATERAL SCLEROSIS IN JAPAN |
EISAI |
Wed, 03/23/2022 - 22:27 |
Regulus Therapeutics Announces Initiation of Preclinical Studies in Amyotrophic Lateral Sclerosis under a Collaboration Agreement with Harvard's Brigham and Women's Hospital |
Regulus Therapeutics |
Mon, 02/28/2022 - 06:46 |
The HEALEY ALS Platform Trial announces first participants enrolled for investigational product SLS-005 (Trehalose) |
Massachusetts G... |
Mon, 11/29/2021 - 19:15 |
ILEX Medical to Invest 10 million NIS ($3.2 million) |
Kadimastem |
Mon, 08/16/2021 - 18:08 |
$2.85 million awarded to create new platform to accelerate and support ALS research |
University of A... |
Wed, 07/28/2021 - 21:06 |
Johns Hopkins Medicine Suggests Eliminating Nerve Cell Protein May Stop ALS, Dementia |
Johns Hopkins H... |
Thu, 07/15/2021 - 04:24 |
California Passes $15 Million in Funding for the Treatment and Care of People Living with ALS |
ALS Association |
Wed, 04/14/2021 - 16:28 |
Fruit Flies and Cellular Demise Zeroing in on the Causes of ALS |
ArizonaUniv |
Wed, 04/14/2021 - 05:29 |
ALS Association Calls on FDA To Follow the Lead Of Canadian and European Counterparts in Expediting Access To Promising New Treatment |
ALS Association |
Thu, 03/25/2021 - 23:04 |
Worlds Largest Public ALS Data Portal Launched |
Gladstone Institutes |
Fri, 03/19/2021 - 04:31 |
The ALS Association, Muscular Dystrophy Association, and ALS Finding a Cure Provide Additional Funding for Novel ALS Research |
ALS Association |